<< Read Full Article
<< Read Full Article
Now that Biogen Idec(BIIB Quote) is entertaining offers to be acquired, how much is the company worth?
There are no guarantees that Biogen can attract a buyer interested in paying what is expected to be a top-dollar price, but here are some thoughts (and guesses) on what the company might fetch:
- At its Friday after-hours price of $81.60 per share, Biogen Idec is valued at $23.5 billion. At this valuation, a prospective buyer would be paying 7.6 times expected 2007 revenue of $3.1 billion, or about 6.5 times expected 2008 revenue of $3.6 billion. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |
Connect with TheStreet